It has been an excellent third-quarter earnings season so far. Of the S&P 500 stocks that have reported earnings, a majority have beaten analyst estimates.  According to Factset Insight, 56% of the index companies have reported earnings so far in Q3 2021. Of those, 82% beat the consensus earnings per share (EPS). That’s higher than
0 Comments
I first came in contact with Palantir (NYSE:PLTR) stock earlier this year and immediately knew it was something special. The underlying bullish thesis was clear, so I traded it successfully in the past few months. The easiest opportunities came when it fell in sympathy to other small-cap stocks. Source: Ascannio / Shutterstock.com The problem with
0 Comments
Download Preston’s 1 page checklist for finding great stock picks: http://buffettsbooks.com/checklist Preston Pysh is the #1 selling Amazon author of two books on Warren Buffett. The books can be found at the following location: The FED is short for the U.S. Federal Reserve. The mission of the FED is to care for the U.S. economy.
0 Comments
The Ascending Triangle: -It resembles accumulation. -It is a bullish pattern. -It doesn’t have to happen on an uptrend, but it is very helpful when it does. -The top of the triangle is fairly straight and the bottom of the triangle is ascending. The stock ascends and descends between these two lines of the triangle.
0 Comments
The cost of healthcare can be overwhelming. Even with insurance, individuals and families often find themselves spending a significant amount of money on medical costs. The average family of four with employer-provided insurance and an income of $100,000 will likely pay $12,500 in healthcare expenses. This equates to roughly 13% of the family’s income. Flexible
0 Comments
We have seen a number of new thematic ETFs launched this year. Some of them make sense and some don’t. But here’s a new ETF that provides investors a convenient way to profit from a new industry with massive growth potential. Mobileye: https://www.zacks.com/stock/quote/MBLY?cid=CS-YOUTUBE-FT-VID Cisco Systems: https://www.zacks.com/stock/quote/CSCO?cid=CS-YOUTUBE-FT-VID Skyworks Solutions: https://www.zacks.com/stock/quote/SWKS?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: http://stocktwits.com/ZacksResearch Follow
0 Comments
Over the trailing year, a majority of my single-company opinions have been at least middle of the road for obvious reasons. Although I do have broader economic concerns, benchmark indices have proven resilient. So, my headline to consider exiting Novavax (NASDAQ:NVAX) stock might seem controversial. Source: Ascannio/Shutterstock.com However, I genuinely believe taking the green ink
0 Comments
If you’ve read my prior articles on Ocugen (NASDAQ:OCGN), you know full well my heavily bearish view about OCGN stock. What’s the story here? The company is trying to bring Covaxin, a Covid-19 vaccine candidate developed by India’s Bharat Biotech, to the U.S. and Canada. Source: shutterstock.com/PhotobyTawat So far, it’s made little progress obtaining Emergency
0 Comments
CNBC’s Jim Cramer on Friday took comfort in a prediction by Dr. Scott Gottlieb that the pandemic phase of Covid could be over by January. “Dr. Gottlieb basically said the war’s over, and that’s just incredible,” Cramer said. Gottlieb, who had served as FDA chief under former President Donald Trump, is currently a Pfizer board
0 Comments
Coca-Cola (NYSE:KO) is the best dividend stock you can buy today. There, I said it. Now, looking at its yield of around 3%, you might be thinking that you can find investments with higher payouts than KO stock. Source: ©iStock.com/rsi1986 And you’d be right. But income investors should never consider yield alone. Just as important,
0 Comments
If special purpose acquisition companies have jumped the shark, they may have done so with Digital World Acquisition (NASDAQ:DWAC). The so-called Trump special purpose acquisition company (SPAC), Digital World is the blank-check firm that will take the former president’s media firm Trump Media & Technology Group (TMTG) public. Undergirding DWAC stock is the much-eyeballed social
0 Comments